UPDATE: UBS Upgrades AbbVie By: Benzinga via Benzinga July 28, 2014 at 11:20 AM EDT UBS analyst Marc Goodman upgraded AbbVie (NYSE: ABBV) from Neutral to Buy and raised the price target to $67 based on several key ... Read More >> Related Stocks: AbbVie